Observational - no intervention clinical trials

LATe TreatmENT Related Toxicity in Melanoma (LATENT)

This study looks at the long-term side effects of immunotherapy for advanced melanoma. Researchers will review existing medical records of patients who responded well to treatment for at least three years, aiming to improve future patient care and support.